Back
Protara Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
TARA
Protara Therapeutics, Inc.
Last Price:
$5.11
Seasonality Move:
-16.66%
7 Day Trial
ALL ACCESS PASS
$
7
Protara Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Protara Therapeutics, Inc. has on average historically fallen by 16.4% based on the past 11 years of stock performance.
-
Protara Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Protara Therapeutics, Inc. Stock Undervalued?The current Protara Therapeutics, Inc. [TARA] share price is $5.11. The Score for TARA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
TARA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Protara Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Protara Therapeutics, Inc. has on average historically fallen by 16.4% based on the past 11 years of stock performance.
Protara Therapeutics, Inc. Stock Rating
Sell
23
Protara Therapeutics, Inc. (TARA)
is a Sell
Is Protara Therapeutics, Inc. overpriced?
-
Protara Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Protara Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protaratx.com
52-Week Data
52-Week High:
7.82
52-Week Low:
2.77
Prediction Charts
Market Cap:
280.2M
Price in USD:
5.11
Volume:
511.5K
Beta:
1.28
Technical Analysis
SMA50:
6.03
SMA100:
5.90
SMA200:
4.81
52-Wk Change:
19.11%
Stock Predictions
-
Is Protara Therapeutics, Inc. stock public?Yes, Protara Therapeutics, Inc. is a publicly traded company.
-
What is the Protara Therapeutics, Inc. stock quote today?The Protara Therapeutics, Inc. stock price is 5.11 USD today.
-
How to buy Protara Therapeutics, Inc. stock online?You can buy Protara Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 5.32 | 5.42 | 5.49 | 5.32 |
| Mar-17 | 5.41 | 5.45 | 5.46 | 5.33 |
| Mar-18 | 5.40 | 5.27 | 5.46 | 5.18 |
| Mar-19 | 5.23 | 5.30 | 5.45 | 5.06 |
| Mar-20 | 5.30 | 5.21 | 5.40 | 5.18 |
| Mar-23 | 5.28 | 5.16 | 5.40 | 5.09 |
| Mar-24 | 5.12 | 5.01 | 5.23 | 4.94 |
| Mar-25 | 5.03 | 5.31 | 5.49 | 5.03 |
| Mar-26 | 5.25 | 5.19 | 5.49 | 5.16 |
| Mar-27 | 5.14 | 4.94 | 5.32 | 4.92 |
| Mar-30 | 4.93 | 4.85 | 5.00 | 4.80 |
| Mar-31 | 4.93 | 5.21 | 5.22 | 4.93 |
| Apr-1 | 5.25 | 5.04 | 5.35 | 4.98 |
| Apr-2 | 4.90 | 5.11 | 5.13 | 4.86 |
Protara Therapeutics, Inc. Earnings
Protara Therapeutics, Inc. Earnings Report: Per Share Protara Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protara Therapeutics, Inc. Forecast Revenue Growth
Protara Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protara Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.27 per share, and an increase next year of $0.15 per share.
* Protara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.